title: Breast cancer: Should we assess HER2 status by Oncotype DX?
authors.forename: Michail
authors.initials: M
authors.lastname: Ignatiadis
authors.forename: Christos
authors.initials: C
authors.lastname: Sotiriou
mesh_terms: D001681:Biological Assay / Q000295:instrumentation*; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology; D005260:Female; D018734:Genes, erbB-2 / Q000235:genetics*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence / Q000295:instrumentation / Q000379:methods; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases